Educational Scabies Video

Best Practices & Innovations In Pediatric Dermatology

with Anthony J. Mancini, MD

At this year’s Pediatric Dermatology 2022 conference hosted by Pediatrics360, Dr. Anthony Mancini discussed the safety and efficacy of novel Natroba (spinosad) in eradicating scabies infestations in patients under the age of 18.1

Watch as Dr. Mancini provides insights into:

  • The targeted, topical properties of Natroba that are essential to eradicating scabies mites1,2
  • The “complete cure” outcomes that is entirely unique among scabicides1,3-6
  • The limited number of adverse reactions reported in two, phase III clinical trials1

About Dr. Mancini

Dr. Anthony Mancini is Professor of Pediatrics and Dermatology at Northwestern University Feinberg School of Medicine and Pediatric Dermatologist/Division Head at Ann and Robert H. Lurie Children’s Hospital.

Visit Natroba to learn more about the only scabicide that meets new FDA criteria for a “complete cure”.1